or
Bookmark and Share
Flame retardant resin composition and laminate using the same
   
Document Number
US Patent 5932637
Issued Date
August 3, 1999
Link
Inventors
Map
Abstract
A flame-retardant resin composition which comprises (A) 100 parts by weight of an unhalogenated epoxy resin having at least two epoxy groups in one molecule, (B) 20 to 205 parts by weight of a maleimide compound having at least one maleimido group in one molecule, (C) 20 to 65 parts by weight of a curing agent having an amino group and (D) a phosphorus compound in a proportion of 0.5 to 4.5 parts by weight in terms of phosphorus element per 100 parts by weight of a total of the components (A), (B) and (C), provided that the proportion of nitrogen element contained in the composition is 2.0 to 10.0 parts by weight per 100 parts by weight of the total composition. The above flame-retardant resin composition has a high flame retardance without adding a halogen compound and does not deteriorate the characteristics of commercial products.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
18
Comments:
no comments yet
Published
August 3, 1999
Application Number
08/979,540
Filed
November 26, 1997
US Classification
523/451   523/452 523/455
Int'l Classification
C08K   5/00   (20060101)   C08L   63/00   (20060101)   C08K   5/49   (20060101)   C08K   5/3417   (20060101)   C08G   59/00   (20060101)   C08G   59/56   (20060101)   C08G   59/40   (20060101)   H05K   1/03   (20060101)  
USPTO Field of Search
523/455   523/451   523/452  
Related Patents
6716530 - RESIN COMPOUND FOR FABRICATING INTERLAYER DIELECTRIC OF PRINTED WIRING BOARD, RESIN SHEET AND RESIN APPLIED-COPPER FOIL FOR FORMING INSULATION LAYER USING THE RESIN COMPOUND, AND COPPER-CLAD LAMINATE USING THEM - Owned by Mitsui Mining & Smelting Co., Ltd. (Tokyo,JP)

The present invention provides a resin applied-copper foil, which is free of halogen elements, having high flame retardancy, excellent water resistance, heat resistance, and good peeling strength between a base material and copper foil. To provide the a resin compound used for fabricating an interlayer dielectric of a printed wiring board, the resin compound comprises an epoxy-based resin which includes: an epoxy resin curing agent having 5 to 25% by weight of nitrogen; and maleimide compounds having thermosetting properties, and the resin compound further has composition which is free of halogen elements.

6774163 - Flame retardants for polymers comprising a mixture of two different aryl phosphates, their preparation and their use - Owned by Bayer Chemicals AG (Leverkusen,DE)

The present invention relates to a novel flame retardant system for polymers comprising a mixture of two different aryl phosphates, to its preparation, and to its use.

6337394 - Compounds - Owned by AstraZeneca AB (Sodertalje,SE)

There is provided compounds of formula I, ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sub.x, Y, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.

6838478 - Amino acid derivatives and their use as thrombin inhibitors - Owned by AstraZeneca AB (Sodertalje,SE)

There is provided compounds of formula I, ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.x, Y, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.

6576657 - Amidino derivatives and their use as thrombin inhibitors - Owned by AstraZeneca AB (Sodertalje,SE)

There is provided compounds of formula I, ##STR1## wherein R.sup.1, R.sub.x, Y, R.sup.y, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us